Guinea-Bissau has halted a controversial US-funded hepatitis B vaccine trial that would have involved about 14,000 babies, after it failed to secure government approval. The study, led by the Bissau-based Bandim Health Project and backed by $1.6m from the US CDC, drew global criticism for withholding WHO-recommended birth doses from one group of infants.
Guinea-Bissau halts US-funded hepatitis B vaccine trial
Source: Al Jazeera